Anthem Biosciences Ltd share price logo

Anthem Biosciences Ltd

NSE: ANTHEM

BSE: 544449

Mid Cap

Pharma Sector

₹907.40

-35.45

(-3.76%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Anthem Biosciences shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+25%

Searches for Anthem Biosciences on INDmoney have increased by 25% over the last 30 days.

Investment activity on INDmoney

-32.05%

Investment activity in Anthem Biosciences among INDmoney users has decreased by 32.05% over the last 30 days.

Among the most traded stocks

256th

Anthem Biosciences was the 256th most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

22 days

INDmoney investors hold Anthem Biosciences shares for an average of 22 days.

Key Events for Anthem Biosciences

Last Dividend Declared

₹2.00 per share, declared on 19/05/2026

View Dividend History

Anthem Biosciences Stock Performance

as on September 16, 2026 at 8:49 pm IST

  • Day's Low

    Day's High

    ₹903.00
    ₹953.75
    downward going graph

    0.48%

    Downside

    5.11%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹579.15
    ₹977.55
    downward going graph

    36.17%

    Downside

    7.73%

    Upside

    downward going graph

Anthem Biosciences share price movements today

Previous Close
₹942.85
Open
₹907.05
Volume
9.82L
Upper Circuit
₹1,131.40
Lower Circuit
₹754.30
Day's Low - High
₹903.00 - ₹953.75
52 Week Low - High
₹579.15 - ₹977.55

Anthem Biosciences Historical Returns

1 Month Return
+ 4.99 %
3 Month Return
+ 22.5 %
1 Year Return
+ 13.35 %
3 Year Return
+ 29.1 %
5 Year Return
+ 29.1 %

Anthem Biosciences Fundamentals

as on September 16, 2026 at 3:19 pm IST

Market Cap

₹53,114.36 Cr

Return on Equity (ROE)

23.7

PE Ratio (TTM)

91.8

Return on capital employed (ROCE)

30.98

Industry PE ratio

51.81

Beta (LTM)

0.59

P/B Ratio

11.57

Dividend Yield

0.3

PEG Ratio

75.24

Quarterly Earnings Growth YOY

-11.67

EPS (TTM)

10.54

Book Value

54.16

Anthem Biosciences Stock Valuation

as on September 16, 2026 at 3:19 pm IST

Anthem Biosciences in the last 5 years

  • Overview

  • Trends

Lowest (62.63x)

April 2, 2026

Industry (51.81x)

September 11, 2026

Today (91.80x)

September 11, 2026

Highest (95.74x)

September 17, 2025

LowHigh

Today’s Price to Earnings Ratio: 91.80x

Anthem Biosciences Technical Analysis

Track how Anthem Biosciences technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish4
Bullish10
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
0.92
Bullish
CCI (20)
520
Bearish
RSI (14)
69.81
Neutral
Momentum (10)
4.15
Bullish
ADI (14)
31.99
Bullish
Ultimate Oscillator (7,14,28)
28.83
Bearish

Moving Averages

Name

Value

Action

SMA (20)
908.61
Bullish
EMA (20)
908.57
Bullish
VWMA (20)
908.85
Bullish
SMA (50)
906.68
Bullish
EMA (50)
907.73
Bullish
SMA (200)
913.72
Bearish
EMA (200)
913.47
Bearish
KAMA (200)
906.48
Bullish
DEMA (200)
904.37
Bullish

Anthem Biosciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anthem Biosciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Anthem Biosciences Ltd image
Anthem Biosciences Ltd
BUY53,114.365.82%0.515912,124
Ipca Laboratories Ltd image
Ipca Laboratories Ltd
BUY49,025.8010.06%0.611,1919,646
J B Chemicals & Pharmaceuticals Ltd image
J B Chemicals & Pharmaceuticals Ltd
BUY38,676.9935.83%0.507094,147
Dr Reddys Laboratories Ltd image
Dr Reddys Laboratories Ltd
HOLD95,570.893.22%0.594,15733,700
Abbott India Ltd image
Abbott India Ltd
BUY55,515.634.88%0.001,4146,445
See all

Market expectation of Anthem Biosciences Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Anthem Biosciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
338.59
524.96
497.81
483.2
540.21
550.03
423.15
610.94
418.22
Other Income
19.46
27.85
24.37
14.06
22.81
48.23
33.53
52.19
24.89
Total Income
358.05
552.8
522.18
497.26
563.02
598.26
456.68
663.14
443.11
Expenses
217.69
329.73
338.3
288
348.72
332.12
291.32
343.73
267.65
Operating Profit
120.9
195.23
159.51
195.2
191.49
217.91
131.83
267.21
150.57
Operating Profit Margin %
35.71%
37.19%
32.04%
40.4%
35.45%
39.62%
31.15%
43.74%
36%
Profit Before Interest, Tax and Depreciation
140.36
223.07
183.88
209.26
214.3
266.13
165.36
319.41
175.46
Interest
3.71
3.55
2.55
0.52
1.61
3.03
0.35
1.9
0.89
Depreciation
18.68
19.99
20.28
30.42
26.45
33.5
34.53
39.59
29.99
Profit Before Tax
117.97
199.53
161.05
178.32
186.24
229.6
130.48
277.92
144.58
Tax Paid
35.6
37.6
36.72
95.69
50.46
56.17
37.66
88.16
24.64
Profit After Tax
82.38
161.93
124.33
82.62
135.79
173.43
92.82
189.76
119.94
Total Net profit including share of profit / Loss from associate company
82.38
161.93
124.33
82.62
135.79
173.43
92.82
189.76
119.94
EPS
1.47
2.9
2.22
1.48
2.43
3.09
1.65
3.38
2.13
Actual EPS
1.47
2.9
2.22
1.48
2.43
3.09
1.65
3.38
2.13
Adjusted EPS
1.47
2.9
2.22
1.48
2.43
3.09
1.65
3.38
2.13
Diluted EPS
1.47
2.84
2.21
1.47
2.42
3.09
1.64
3.34
2.11

Anthem Biosciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
1,056.92
1,419.37
1,844.55
2,124.33
Other Income
138.87
63.7
85.73
155.78
Total Income
1,195.79
1,483.07
1,930.29
2,280.12
Expenses
628.04
914.39
1,173.72
1,314.91
Operating Profit
428.88
504.98
670.83
809.42
Operating Profit Margin %
40.58%
35.58%
36.37%
38.1%
Profit Before Interest, Tax and Depreciation
567.76
568.68
756.57
965.2
Interest
6.76
9.54
10.33
6.89
Depreciation
63.7
81.82
89.37
134.07
Profit Before Tax
497.3
477.32
656.87
824.24
Tax Paid
112.11
110.01
205.61
232.45
Profit After Tax
385.19
367.31
451.26
591.79
Total Net profit including share of profit / Loss from associate company
385.19
367.31
451.26
591.79
EPS
6.75
6.48
8.07
10.55
Actual EPS
6.75
6.48
8.07
10.55
Adjusted EPS
6.75
6.48
8.07
10.55
Diluted EPS
6.75
6.48
8.04
10.43

Anthem Biosciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
165.52
277.64
332.91
305.99
140.15
270.55
844.49
Cash Flow from Investing Activities
-109.36
-196.03
-205.44
-365.77
-40.84
-146.98
-701.89
Cash Flow from Financing Activities
-47.63
-63.27
180.67
63.96
-77.19
-135.65
-39.98
Net Cash Flow
8.53
18.34
308.14
-6.06
-158.49
-12.08
102.6

Anthem Biosciences Stock Shareholding Pattern

Numbers in percentages

Dec 2024
Jul 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
77.23%
74.69%
74.69%
74.69%
74.68%
71.42%
DII
0%
3.61%
7.22%
7.6%
11.55%
13.48%
FII
0%
1.5%
1.67%
1.36%
1.28%
2.58%
Public
0%
20.2%
16.42%
16.35%
12.5%
12.53%
Total Outstanding Shares
55,90,77,100
56,16,10,051
56,16,10,051
56,16,10,051
56,17,13,851
56,33,84,760
Total Shareholders
16
8,25,844
2,17,681
1,99,492
1,80,220
1,73,273

Mutual Funds Buying / Exiting Anthem Biosciences

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Anthem Biosciences

Sorted by largest increase in holding, month-over-month.

No buying activity data available right now

No buying activity data available right now

Mutual Funds Exiting Anthem Biosciences

Sorted by largest decrease in holding, month-over-month.

Fund Name

Value of Holding

Decrease (MoM)

Holding %

HDFC Flexi Cap Fund -Direct Plan - Growth Option

HDFC Flexi Cap Fund -Direct Plan - Growth Option

₹704.65 Cr

₹45.48 Cr (-6.06%)

0.61%

Anthem Biosciences Corporate Actions

View detailed summary of the earnings and dividend history of Anthem Biosciences.

  • Anthem Biosciences Ltd Earnings Results

    Anthem Biosciences Ltd’s net profit fell -11.67% since last year same period to ₹119.94Cr in the Q1 2026-2027. On a quarterly growth basis, Anthem Biosciences Ltd has generated -36.79% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Anthem Biosciences Ltd Dividends May,2026

    In the quarter ending March 2026, Anthem Biosciences Ltd has declared dividend of ₹2.00 per share on 19 May 2026 - translating a dividend yield of 0.21%.

    Read More about Dividends

Indices Featuring Anthem Biosciences Stock

Check stock indices that include Anthem Biosciences.

S&P BSE 400 MidSmallCap

₹12,418.15

+11.31 (▲0.09%)

BSE Healthcare

₹50,402.24

-76.57 (▲0.15%)

Nifty LargeMidcap 250

₹16,135.25

+47.80 (▲0.30%)

Nifty 500

₹22,546.80

+69.35 (▲0.31%)

Nifty Midcap 150

₹22,397.55

+38.75 (▲0.17%)

S&P BSE 250 SmallCap

₹7,048.27

-4.35 (▲0.06%)

Nifty MidSmallcap 400

₹20,764.60

+13.90 (▲0.07%)

BSE 500

₹35,277.41

+107.79 (▲0.31%)

Insights on Anthem Biosciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 12.50% to 12.53% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 10.12% to 11.15% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 1.28% to 2.58% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ANTHEM stock has moved up by 22.5%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 74.68% to 71.42% in Jun 2026 quarter

About Anthem Biosciences Ltd

Anthem Biosciences Limited was originally incorporated as Anthem Biosciences Private Limited dated June 13 2006 issued by RoC. Subsequently Company was converted from a Private Company to a Public Company followed by the change in name of the Company to Anthem Biosciences Limited and a Certificate of Incorporation upon the conversion was issued by RoC on December 10 2024.The Company has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation other organic compounds such as speciality organic molecules biologically active peptides etc. which are highvalue products used in drug agrochemical and speciality chemicals industries.The Company started operations at Unit I and set up a Custom Synthesis Plant with a capacity of 6 KL in year 2007. It commenced discovery biology services with a fermentation capacity of 2 KL in 2008. It expanded the Custom Synthesis Plant at Unit I increasing its capacity from 6 KL to 24 KL in 2010. It set up a high potent lab at Unit I Bommasandra Facility in 2016. The Company was merged with Anthem Cellutions India Private Limited by acquiring 100 of its share capital in November 2017. It set up a flow chemistry lab scale and solid phase peptide synthesis GMP lab with a capacity of 6 KL at Unit 1. It commenced operations of the Company at Unit II and set up an automated GMP compliant custom synthesis plant with a capacity of 128 KL and a fermentation plant with a capacity of 80 KL in 201819. In year 2020 Company started operations to biological unit 2 earmarked for a specific client. It expanded the custom synthesis plant set up at Unit II increasing its capacity to 246 KL. In FY 2024 Company set up a wholly owned subsidiary Neoanthem Lifesciences Private Limited and commenced operations at Unit III for development in projects. Company is planning an Offer for Sale by raising funds from public through IPO aggregating to Rs 3395 Cr Equity Shares..

Revenue: ₹418.22Cr as on June 2026 (Q1 FY27)
Net Profit: ₹119.94Cr as on June 2026 (Q1 FY27)
Listing date: 21 Jul, 2025
Chairperson Name: Ajay Bhardwaj
OrganisationAnthem Biosciences Ltd
HeadquartersBangalore
IndustryPharmaceuticals
CEOAjay Bhardwaj
E-voting on sharesClick here to vote

FAQs

What is Anthem Biosciences share price today?

Anthem Biosciences share price today stands at ₹907.4 as on at the close of the market. Anthem Biosciences share today touched a day high of ₹953.75 and a low of ₹903.

What is the 52 week high and 52 week low range for Anthem Biosciences share?

Anthem Biosciences touched a 52 week high of ₹977.55 and a 52 week low of ₹579.15. Anthem Biosciences share price today i.e. is closed at ₹907.4, which is -7.18% down from its 52 week high and 56.68% up from its 52 week low.

What is Anthem Biosciences's market capitalisation today?

Anthem Biosciences market capitalisation is ₹53,114.36 Cr as on .

How to buy Anthem Biosciences shares?

To buy Anthem Biosciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ANTHEM or Anthem Biosciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Anthem Biosciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Anthem Biosciences trading volume today?

Anthem Biosciences trading volume is 9.82L as on . This means that 9.82L shares of Anthem Biosciences were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Anthem Biosciences shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest in Anthem Biosciences has increased while investment activity has decreased over the past 30 days, and the average INDmoney investor holds the stock for 22 days. This reflects platform activity only and is not investment advice.